1.Barker, DJ. The origins of the developmental origins theory. J Intern Med. 2007; 261, 412–417.
2.Ross, MG, Beall, MH. Adult sequelae of intrauterine growth restriction. Semin Perinatol. 2008; 32, 213–218.
3.Silver, LE, Decamps, PJ, Korst, LM, Platt, LD, Castro, LC. Intrauterine growth restriction is accompanied by decreased renal volume in the human fetus. Am J Obstet Gynecol. 2003; 188, 1320–1325.
4.Latini, G, De, MB, Del, VA, et al. Foetal growth of kidneys, liver and spleen in intrauterine growth restriction: “programming” causing “metabolic syndrome” in adult age. Acta Paediatr. 2004; 93, 1635–1639.
5.Moritz, KM, Wintour, EM. Functional development of the meso- and metanephros. Pediatr Nephrol. 1999; 13, 171–178.
6.Henry, TQ, Mansano, RZ, Nast, CC, et al. GDNF and MAPK-ERK pathway signaling is reduced during nephrogenesis following maternal under-nutrition. J Dev Origins Health Disease. 2010; 1, 67–74.
7.Ojeda, NB, Grigore, D, Alexander, BT. Intrauterine growth restriction: fetal programming of hypertension and kidney disease. Adv Chronic Kidney Dis. 2008; 15, 101–106.
8.Schreuder, MF, Nyengaard, JR, Remmers, F, van Wijk, JA, Delemarre-van de Waal, HA. Postnatal food restriction in the rat as a model for a low nephron endowment. Am J Physiol Renal Physiol. 2006; 291, F1104–F1107.
9.Pham, TD, MacLennan, NK, Chiu, CT, et al. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol. 2003; 285, R962–R970.
10.Abdel-Hakeem, AK, Henry, TQ, Magee, TR, et al. Mechanisms of impaired nephrogenesis with fetal growth restriction: altered renal transcription and growth factor expression. Am J Obstet Gynecol. 2008; 199, 252–257.
11.Hida, M, Omori, S, Awazu, M. ERK and p38 MAP kinase are required for rat renal development. Kidney Int. 2002; 61, 1252–1262.
12.Coles, HS, Burne, JF, Raff, MC. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development. 1993; 118, 777–784.
13.Okada, T, Iwamoto, A, Mukamoto, M, et al. Perinatal development of the rat kidney: apoptosis and epidermal growth factor. Congenit Anom (Kyoto). 2003; 43, 161–167.
14.Sanz, AB, Santamaria, B, Ruiz-Ortega, M, Egido, J, Ortiz, A. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol. 2008; 19, 1634–1642.
15.Magee, TR, Tafti, SA, Desai, M, et al. Maternal undernourished fetal kidneys exhibit differential regulation of nephrogenic genes including downregulation of the Notch signaling pathway. Reprod Sci. 2011; 18, 563–576.
16.Welham, SJ, Wade, A, Woolf, AS. Protein restriction in pregnancy is associated with increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney Int. 2002; 61, 1231–1242.
17.Gilbert, JS, Nijland, MJ. Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul Integr Comp Physiol. 2008; 295, R1941–R1952.
18.Ozaki, T, Nishina, H, Hanson, MA, Poston, L. Dietary restriction in pregnant rats causes gender-related hypertension and vascular dysfunction in offspring. J Physiol. 2001; 530, 141–152.
19.Brawley, L, Itoh, S, Torrens, C, et al. Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring. Pediatr Res. 2003; 54, 83–90.
20.Woods, LL, Ingelfinger, JR, Rasch, R. Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Physiol Regul Integr Comp Physiol. 2005; 289, R1131–R1136.
21.Livak, KJ, Schmittgen, TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001; 25, 402–408.
22.Choi, GY, Tosh, DN, Garg, A, et al. Gender-specific programmed hepatic lipid dysregulation in intrauterine growth-restricted offspring. Am J Obstet Gynecol. 2007; 196, 477–477.
23.Georgas, K, Rumballe, B, Wilkinson, L, et al. Use of dual section mRNA in situ hybridisation/immunohistochemistry to clarify gene expression patterns during the early stages of nephron development in the embryo and in the mature nephron of the adult mouse kidney. Histochem Cell Biol. 2008; 130, 927–942.
24.Desai, M, Gayle, D, Babu, J, Ross, MG. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol. 2005; 288, R91–R96.
25.Jelks, A, Belkacemi, L, Han, G, et al. Paradoxical increase in maternal plasma leptin levels in food-restricted gestation: contribution by placental and adipose tissue. Reprod Sci. 2009; 16, 665–675.
26.Schreuder, MF, Nauta, J. Prenatal programming of nephron number and blood pressure. Kidney Int. 2007; 72, 265–268.
27.do Carmo Pinho Franco, M, Nigro, D, Fortes, ZB, et al. Intrauterine undernutrition–renal and vascular origin of hypertension. Cardiovasc Res. 2003; 60, 228–234.
28.Fowden, AL, Giussani, DA, Forhead, AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006; 21, 29–37.
29.Welham, SJ, Riley, PR, Wade, A, Hubank, M, Woolf, AS. Maternal diet programs embryonic kidney gene expression. Physiol Genomics. 2005; 22, 48–56.
30.Koseki, C, Herzlinger, D, Al-Awqati, Q. Apoptosis in metanephric development. J Cell Biol. 1992; 119, 1327–1333.
31.Foley, JG, Bard, JB. Apoptosis in the cortex of the developing mouse kidney. J Anat. 2002; 201, 477–484.
32.Hartman, HA, Lai, HL, Patterson, LT. Cessation of renal morphogenesis in mice. Dev Biol. 2007; 310, 379–387.
33.Wlodek, ME, Mibus, A, Tan, A, et al. Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. J Am Soc Nephrol. 2007; 18, 1688–1696.
34.Carev, D, Krnic, D, Saraga, M, Sapunar, D, Saraga-Babic, M. Role of mitotic, pro-apoptotic and anti-apoptotic factors in human kidney development. Pediatr Nephrol. 2006; 21, 627–636.
35.Wajant, H. The Fas signaling pathway: more than a paradigm. Science. 2002; 296, 1635–1636.
36.Jones, NL, Day, AS, Jennings, HA, Sherman, PM. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun. 1999; 67, 4237–4242.
37.Muschen, M, Warskulat, U, Douillard, P, Gilbert, E, Haussinger, D. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology. 1998; 27, 200–208.
38.Sorenson, CM, Rogers, SA, Korsmeyer, SJ, Hammerman, MR. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am J Physiol. 1995; 268, F73–F81.
39.Liu, WH, Hsiao, HW, Tsou, WI, Lai, MZ. Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J. 2007; 26, 1660–1669.
40.Duechler, M, Shehata, M, Schwarzmeier, JD, et al. Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. Leukemia. 2005; 19, 260–267.